K Claire Simon

Summary

Affiliation: Harvard University
Country: USA

Publications

  1. pmc Epstein-Barr virus neutralizing antibody levels and risk of multiple sclerosis
    Kelly Claire Simon
    Department of Nutrition, Harvard School of Public Health, Boston, MA 02115, USA
    Mult Scler 18:1185-7. 2012
  2. pmc XVI European Charcot Foundation lecture: nutrition and environment: can MS be prevented?
    Kelly Claire Simon
    Department of Nutrition, Harvard School of Public Health, Boston, MA 02115, USA
    J Neurol Sci 311:1-8. 2011
  3. pmc Genetic predictors of 25-hydroxyvitamin D levels and risk of multiple sclerosis
    Kelly Claire Simon
    Department of Nutrition, Harvard School of Public Health, 677 Huntington Ave, Building 2, 3rd Floor, Boston, MA 02115, USA
    J Neurol 258:1676-82. 2011
  4. pmc Calcium channel blocker use and risk of Parkinson's disease
    Kelly Claire Simon
    Department of Nutrition, Harvard School of Public Health, Boston, Massachusetts 02115, USA
    Mov Disord 25:1818-22. 2010
  5. pmc EBNA1 and LMP1 variants in multiple sclerosis cases and controls
    K C Simon
    Department of Nutrition, Harvard School of Public Health, Boston, MA, USA
    Acta Neurol Scand 124:53-8. 2011
  6. pmc Polymorphisms in vitamin D metabolism related genes and risk of multiple sclerosis
    K Claire Simon
    Department of Nutrition, Harvard School of Public Health, Boston, MA 02115, USA
    Mult Scler 16:133-8. 2010
  7. pmc Reproductive factors, exogenous estrogen use, and risk of Parkinson's disease
    Kelly Claire Simon
    Department of Nutrition, Harvard School of Public Health, Boston, Massachusetts, USA
    Mov Disord 24:1359-65. 2009
  8. pmc Hypertension, hypercholesterolemia, diabetes, and risk of Parkinson disease
    Kelly Claire Simon
    Department of Epidemiology, Harvard School of Public Health, Boston, MA 02115, USA
    Neurology 69:1688-95. 2007
  9. pmc Integration of genetic risk factors into a clinical algorithm for multiple sclerosis susceptibility: a weighted genetic risk score
    Philip L De Jager
    Program in Translational NeuroPsychiatric Genomics, Department of Neurology, Brigham and Women s Hospital, Boston, MA 02115, USA
    Lancet Neurol 8:1111-9. 2009
  10. doi request reprint Vitamin D and multiple sclerosis
    Alberto Ascherio
    Department of Epidemiology, Harvard School of Public Health, Boston, MA, USA
    Lancet Neurol 9:599-612. 2010

Detail Information

Publications10

  1. pmc Epstein-Barr virus neutralizing antibody levels and risk of multiple sclerosis
    Kelly Claire Simon
    Department of Nutrition, Harvard School of Public Health, Boston, MA 02115, USA
    Mult Scler 18:1185-7. 2012
    ..2, 95% confidence interval [CI] 0.97-5.1). This association was attenuated after adjustment for anti-EBNA1 IgG Ab titers (RR = 1.4, 95% CI 0.5-3.5). This preliminary finding warrants further study in a larger population...
  2. pmc XVI European Charcot Foundation lecture: nutrition and environment: can MS be prevented?
    Kelly Claire Simon
    Department of Nutrition, Harvard School of Public Health, Boston, MA 02115, USA
    J Neurol Sci 311:1-8. 2011
    ..Epidemiologic observation has provided key insights into environmental and nutritional factors that may alter one's susceptibility to MS, however, there are still many questions in unraveling the etiology of this complex disease...
  3. pmc Genetic predictors of 25-hydroxyvitamin D levels and risk of multiple sclerosis
    Kelly Claire Simon
    Department of Nutrition, Harvard School of Public Health, 677 Huntington Ave, Building 2, 3rd Floor, Boston, MA 02115, USA
    J Neurol 258:1676-82. 2011
    ..91, 95% CI: 0.80, 1.04). This preliminary finding suggests the possibility that the putative beneficial effect of vitamin D on MS risk maybe attenuated in individuals carrying the HLA-DR15 MS risk allele...
  4. pmc Calcium channel blocker use and risk of Parkinson's disease
    Kelly Claire Simon
    Department of Nutrition, Harvard School of Public Health, Boston, Massachusetts 02115, USA
    Mov Disord 25:1818-22. 2010
    ..18, 95% CI: 0.73-1.92), frequency of use or duration of use of CCBs and PD risk was observed (P > 0.2 for all). These findings do not support a role for CCBs in providing neuroprotection against development of PD...
  5. pmc EBNA1 and LMP1 variants in multiple sclerosis cases and controls
    K C Simon
    Department of Nutrition, Harvard School of Public Health, Boston, MA, USA
    Acta Neurol Scand 124:53-8. 2011
    ..Some findings from observational studies, including possible epidemics and differences in prevalence, may be explained if different strains of EBV conferred different MS risk...
  6. pmc Polymorphisms in vitamin D metabolism related genes and risk of multiple sclerosis
    K Claire Simon
    Department of Nutrition, Harvard School of Public Health, Boston, MA 02115, USA
    Mult Scler 16:133-8. 2010
    ..The finding of a marginally significant gene-environment interaction requires replication in larger datasets, but suggests future genetic studies may benefit from considering relevant environmental context...
  7. pmc Reproductive factors, exogenous estrogen use, and risk of Parkinson's disease
    Kelly Claire Simon
    Department of Nutrition, Harvard School of Public Health, Boston, Massachusetts, USA
    Mov Disord 24:1359-65. 2009
    ..The use of postmenopausal hormone use may interact with other risk factors, but findings are preliminary and need confirmation in other populations...
  8. pmc Hypertension, hypercholesterolemia, diabetes, and risk of Parkinson disease
    Kelly Claire Simon
    Department of Epidemiology, Harvard School of Public Health, Boston, MA 02115, USA
    Neurology 69:1688-95. 2007
    ..To determine whether history of hypertension, hypercholesterolemia, or diabetes is associated with risk of Parkinson disease (PD)...
  9. pmc Integration of genetic risk factors into a clinical algorithm for multiple sclerosis susceptibility: a weighted genetic risk score
    Philip L De Jager
    Program in Translational NeuroPsychiatric Genomics, Department of Neurology, Brigham and Women s Hospital, Boston, MA 02115, USA
    Lancet Neurol 8:1111-9. 2009
    ..We investigated the usefulness of an aggregate measure of risk of MS that is based on genetic susceptibility loci. We also assessed the added effect of environmental risk factors that are associated with susceptibility for MS...
  10. doi request reprint Vitamin D and multiple sclerosis
    Alberto Ascherio
    Department of Epidemiology, Harvard School of Public Health, Boston, MA, USA
    Lancet Neurol 9:599-612. 2010
    ....